Français
Movember
Prostate Cancer Canada Network
Our Team
Board of Directors
Halifax/ Atlantic Region
Get Involved
PCC Atlantic News
Research Advisory Panel
Corp. Supporters
Careers at PCC
Privacy Policy
Ethics & Accountability
Testimonials
Where Does Your Dollar Go?
About the Prostate
Early Detection Guidelines
Prevention
Non-Cancerous Prostate Conditions
PSA
Prostate Cancer
What is Cancer?
What is Prostate Cancer?
Prostate Cancer Disease States
PCA3 Test
Prostate Cancer Facts
Glossary
Resources
Treatment
Experimental and Alternative Therapies
P.C. Assessment Tools
Science Behind PCATs
Disclaimer
Risk Assessment Quiz
Risk Factor
Age
Diet
Environmental Factors
Family History
Ethnicity / Nationality
Weight
A History of Success
Research Success Stories
Pilot Grant Program
Pilot Grant Panel
Pilot Grant FAQs
Grant Application Guidelines
Copyright & Trademark Notice
Research Grants From Previous Years
Apply for a Pilot Grant
Request for Applications
Clinician Scientist Award
2012 Clinician Scientist Panel
Clinician Scientist Awards From Previous Years
Clinician-Scientist Award Application
Clinician-Scientist Award Guidelines
2012 Request for Applications: Clinician-Scientist Program
Progress and Final Report
Scientific Medical Community
SMAC Sign In
News Articles
PC Awareness Month
Prostate Cancer News
It's Our Time
Foundation Publications
News Releases
PSAs
The Faces of Prostate Cancer
Events
Movember
Father's Day Walk/Run
PCCN Conference
Tied Together
Wake Up Call Breakfast
Combines for Cures
Community Events
How to Support Us
Host an Information Session
Monthly Giving Program
Sponsor an Event
Volunteer
Volunteer Application
Volunteer Opportunities
Internships
Recognizing Volunteers
FAQs
Advocacy
Campaign to Control Cancer
Shop PCC
Purchase Our Merchandise
GIVE NOW
Ways to Donate
Planned Giving
Monthly Giving Program
Donate by Phone, Mail or Fax
Gifts of Publicly Traded Securities
Charity Car Donation Program
Where Does Your Dollar Go?
Prostate Cancer
What is Cancer?
What is Prostate Cancer?
Prostate Cancer Disease States
PCA3 Test
Prostate Cancer Facts
Glossary
Resources
Treatment
Experimental and Alternative Therapies
For more information visit
www.movember.com
In The News
Prostate Cancer Awareness Day at BC Legislative Assembly
VICTORIA, May 4, 2012- On Monday, May 7, Prostate Cancer Canada (PCC) will host their first Legislative Assembly Day to promote education and awareness of prostate cancer in British Columbia.
Media Advisory - Prostate Cancer Canada celebrates local Halifax hero
HALIFAX, April 25, 2012 /CNW/ - Please join Prostate Cancer Canada and members of the Halifax business community as we celebrate a local hero who has made an extraordinary contribution in the fight against prostate cancer through courage, inspiration and dedication.
Click For Information Archive
Experimental and Alternative Therapies
Hundreds of experimental and alternative therapies for prostate cancer are being studied around the world. A few of these potential treatments are summarized here:
Gene Therapy
Genes that have been specifically created to treat disease are inserted into cells. The Toronto General Hospital is testing one type of gene therapy to improve a man’s odds after prostatectomy. Sometimes prostate cancer returns even after the prostate has been removed because small numbers of cancer cells have already spread to other parts of the body before surgery. Researchers are testing a gene therapy which is used a month before surgery and encourages the body to kill cancer cells that have spread beyond the prostate. This research is still in early stages but the results so far are hopeful.
High Intensity Focused Ultrasound (HIFU)
HIFU is an acoustic ablation technique that uses intersecting, precision focused ultrasound waves to raise the temperature of the target tissue to more than 80 to 90 degrees Celsius in two to three seconds, destroying the targeted cancerous tissues.
HIFU Facts:
a non-invasive therapy device that is available in Canada, Mexico, Europe, parts of Asia and the Dominican Republic
used to treat localized prostate cancer and benign prostatic hyperplasia (BPH) or prostate enlargement
has been used in Japan and Europe for over 10 and five years, respectively
treatments are not covered by provincial health insurance in Canada, as of September 2006
There are two standards of HIFU delivery approved for use in Canada: Sonablate and Albatherm.
Clinical Trials
For more information on clinical trials in prostate cancer, please visit
www.emergingmed.com
or
http://canadatrials.com
which provide comprehensive listings of prostate cancer clinical trials underway in Canada.
For information linking Canadians to cancer services, information and resources visit:
www.cancerview.ca
Twitter feed temporarily unavailable.
Follow Us On Twitter
GIVE NOW!
Ethics and Accountability
About Prostate Cancer
Prostate Cancer News
Careers
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca
Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development
Inorbital